Albumin Microspheres I: Physico-Chemical Characteristics

References

• Baker R. W., Lonsdale H. K. Controlled Release of Biologically Active Agents, A. C. Tanquary, R. C. Lacey. Plenum Press, NY 1974; 15–71
   Google Scholar
• Becker P. Emulsion Theory and Practice, 2nd ed. Reinhold Publishing Co. 1965; 289–293
   Google Scholar
• Benita S., Fickat R., Benoit J. P., Bonnemain B., Samaille J. P., Modoule P. Biodegradable cross-linked albumin microcapsules for embolization. Journal of Microencapsulation 1984; 1: 317–327
   PubMedGoogle Scholar
• Benoit J. P. Microcapsules and microspheres for chemoembolization. Drug Targeting, P. Buri, A. Gumma. Elsevier, Amsterdam 1985; 95–117
   Google Scholar
• Benoit J. P., Fickat R., Benita S. Binding and release mechanism of adriamycin from albumin microcapsules. Proceedings of the 12th International Symposium on controlled release of bioactive materials, GenevaSwitzerland, 1985
   Google Scholar
• Bolton S. Factorial designs in pharmaceutical stability studies. Journal of Pharmaceutical Sciences 1983; 72: 362–366
   PubMed Web of Science ®Google Scholar
• Borodkin S., Tucker F. E. Drug release from hydroxypropyl cellulose-polyvinyl acetate films. Journal of Pharmaceutical Sciences 1974; 63: 1359–1364
   PubMed Web of Science ®Google Scholar
• Burger J. J., McVie J. G. Microspheres for tumour targeting of cytotoxic drugs. Pharmaceutish Weekblad 1985; 7: 27
   Google Scholar
• Burger J. J., Tomlinson E., Deroo J. E., Palmer J. Technetium 99m labeling of albumin microspheres intended for drug targeting. Methods in Enzymology 1985a; 112: 43–56
   PubMed Web of Science ®Google Scholar
• Burger J. J., Tomlinson E., Mulder E. M. A., McVie J. G. Albumin microspheres for intra-arterial tumour targeting. I. Pharmaceutical aspects. International Journal of Pharmaceutics 1985b; 23: 333–344
   Web of Science ®Google Scholar
• Burger J. J., Tomlinson E., McVie J. G. Microparticles intended for microvascular blockage. Drug incorporation and release. Drug Targeting, P. Buri, A. Gumma. Elsevier, Amsterdam 1985c; 81–94
   Google Scholar
• Burgess D. J., Davis S. S. Prednisolone release from albumin microspheres: in vitro, and in vivo, studies by intraarticular injection into rabbits. Journal of Pharmacy and Pharmacology 1986; 38: 23
   Google Scholar
• Dalmark M., Johansen P. Molecular association between doxorubicin (adriamycin) and DNA-derived bases, nucleosides, nucleotides, other aromatic compounds and proteins in aqueous solution. Molecular Pharmacology 1982; 22: 158–165
   PubMed Web of Science ®Google Scholar
• Dal-Palu C., Donaggio E., Dalzotto I., Pessina A. C. Arteriovenous shunts in chirrotic patient studies with human serum albumin microaggregates tagged with I131 (MAA131). Scandinavian Journal of Gasteoenterology 1968; 3: 425–431
   PubMedGoogle Scholar
• Dau-Mauger A., Benoit J. P., Puisieux F. Preparation and characterization of cross-linked human serum albumin microspheres containing 5-fluorouracil. Pharmceutica Acta Helvetica 1986; 61: 119–124
   PubMedGoogle Scholar
• Davis S. S. Drug targeting. Manufacturing Chemist 1986; 57: 42–45
   Google Scholar
• Davis S. S., Hunneyball I. M., Illum L., Ratcliffe J. H., Smith A., Wllson C. G. Recent advances in the use of microspheres for targeted therapy. Drugs under Experimental and Clinical Research 1985; 11: 633–640
   PubMedGoogle Scholar
• Davis S. S., Illum L. The targeting of drugs using polymeric microspheres. British Polymer Journal 1983; 15: 160–164
   Web of Science ®Google Scholar
• Del Maestro R. F., Schosser R., Agerup B. Multiple cerebral and spinal cord blood flow measurements using radioactive microsphere method. Biobliotheca Anatomica No. 18, Current Advances in Basic and Clinical Microcirculatory Research, D. H. Lewis. S. Karger, Basel 1979; 201–263
   Google Scholar
• Desoize B., Jardillier J. C., Kanoun K., Guerin D., Levy M. C. In-vitro, cytotoxic activity of cross-linked protein microcapsules. Journal of Pharmacy and Pharmacology 1986; 38: 8–13
   PubMed Web of Science ®Google Scholar
• Eberth K., Merry J. A comparative study of emulsion prepared by ultrasound and by a conventional method. Droplet size measurements by means of a coulter counter and microscopy. International Journal of Pharmaceutics 1983; 14: 349–353
   Web of Science ®Google Scholar
• El-Samaligy M., Rohdewald P. Triamcinolone diacetate nanoparticles, a sustained release drug delivery system suitable for parenteral administration. Pharmseutica Acta Helvetica 1982; 57: 201–204
   PubMedGoogle Scholar
• Evans R. L. U.S. Patent. 1972a, Biodegradable radioactive particles, 3, 663, 685
   Google Scholar
• Evans R. L. U.S. Patent. 1972b, Biodegradable parenteral microspherules, 3, 663, 687
   Google Scholar
• Florence A. T., Halbert G. W. Drug delivery and targeting. Physical Technology 1985; 16: 164–176
   Google Scholar
• Farmitalia Carlo Erba. Milan, Italy, Personal Communication
   Google Scholar
• Friend D. R., Pangburn S. Site-specific drug delivery. Medicinal Research Reviews 1987; 7: 53–106
   PubMed Web of Science ®Google Scholar
• Fujimoto S., Endoh F., Kitsukawa Y., Okui K., Morimoto Y., Sugibayashi K., Miyakawa A., Suzuki H. Continued in vitro, and in vivo, release of an antitumour drug from albumin microspheres. Experientia 1983; 39: 913–916
   PubMedGoogle Scholar
• Fujimoto S., Endoh F., Miyazaki M., Shrestha R. D., Okui K., Morimoto Y. Intra-arterial administration of heated albumin microspheres containing mitomycin C to rabbits with VX-2 tumor. Japanese Journal of Surgery 1984; 14: 252–257
   PubMedGoogle Scholar
• Gallo J. M. Pharmacokinetic studies of adriamycin delivered via magnetic albumin microspheres and of ibuprofen in synovial fluid. Unpublished Ph.D Thesis, The University of Arizona, USA 1985
   Google Scholar
• Gallo J. M., Gupta P. K., Hung C. T., Perkier D. G. Evaluation of drug delivery following the administration of magnetic albumin microspheres containing adriamycin to the rat. Journal of Pharmaceutical Sciences 1989; 78: 190–194
   PubMed Web of Science ®Google Scholar
• Gallo J. M., Hung C. T., Perrier D. G. Analysis of albumin microsphere preparation. International Journal of Pharmaceutics 1984; 22: 63–74
   Web of Science ®Google Scholar
• Gardner C. R. Potentials and limitations of drug targeting: an overview. Biomaterials 1985; 6: 153–160
   PubMed Web of Science ®Google Scholar
• Gipps E. M. The incorporation of cytotoxics into nanoparticles. Unpublished M. Pharm. Thesis, The Victorian College of Pharmacy, Australia 1983
   Google Scholar
• Goldberg E. P., Iwata H., Longo W. Hydrophilic albumin and dextran ionexchange microspheres for localized chemotherapy. Microspheres and Drug Therapy. Pharmaceutical, Immunological and Medical Aspects, S. S. Davis, L. Ilium, J. G. McVie, E. Tomlinson. Elsevier, New York 1984; 309–326
   Google Scholar
• Goosen M. F. A., Leung Y. F., Chou S., Sun A. M. Insulin albumin microbeads: an implantable biodegradable system. Biomaterials Medical Devices and Artificial Organs 1982; 10: 205–218
   PubMed Web of Science ®Google Scholar
• Goosen M. F. A., Leung Y. F., O'Shea G. M., Chou S., Sun A. M. Slow release of insulin from a biodegradable matrix implanted in diabetic rats. Diabetes 1983; 32: 478–481
   PubMed Web of Science ®Google Scholar
• Gregoriadis G. Targeting of drugs. Nature 1977; 265: 407–411
   PubMed Web of Science ®Google Scholar
• Grisson M., Alter W., Hill J., Vieras F., Eckelman W., Phillips J. Evaluation of first-pass and equilibrium characteristics of technetium-m-labeled vascular markers. Journal of Nuclear Medicine 1979; 20: 654
   Google Scholar
• Gupta P. K., Gallo J. M., Hung C. T., Perrier D. G. Influence of stabilization temperature on the entrapment of adriamycin in albumin microspheres. Drug Development and Industrial Pharmacy 1987a; 13: 1471–1482
   Web of Science ®Google Scholar
• Gupta P. K., Hung C. T., Lam F. C. Factorial design based optimisation of the formulation of albumin microspheres containing adriamycin. Journal of Microencapsulation 1988b; 6(2)147–160
   Google Scholar
• Gupta P. K., Hung C. T., Lam F. C., Pehrier D. G. Albumin microspheres III: Synthesis and characterization of microspheres containing adriamycin and magnetite. International Journal of Pharmaceutics 1988a; 43: 167–177
   Web of Science ®Google Scholar
• Gupta P. K., Hung C. T., Perrier D. G. Albumin microspheres I: Release characteristics of adriamycin. International Journal of Pharmaceutics 1986a; 33: 137–146
   Web of Science ®Google Scholar
• Gupta P. K., Hung C. T., Perrier D. G. Albumin microspheres II: Effect of stabilization temperature on the release of adriamycin. International Journal of Pharmaceutics 1986b; 33: 147–153
   Web of Science ®Google Scholar
• Gupta P. K., Hung C. T., Perrier D. G. Quantitation of release of doxorubicin from colloidal dosage forms using dynamic dialysis. Journal of Pharmaceutical Sciences 1987b; 76: 141–145
   PubMed Web of Science ®Google Scholar
• Gupta P. K., Hung C. T., Rao N. S. A study on the ultrastructural disposition of adriamycin-associated magnetic albumin microspheres in rats. Journal of Pharmaceutical Sciences 1989; 78: 290–294
   PubMed Web of Science ®Google Scholar
• Gupta P. K., Lam F. C., Hung C. T. Investigation of the stability of doxorubicin hydrochloride using factorial design. Drug Development and Industrial Pharmacy 1988c; 14: 1657–1671
   Web of Science ®Google Scholar
• Gupta P. K., Lam F. C., Hung C. T. Albumin microspheres IV. Effect of protein concentration and stabilization time on the release rate of adriamycin. International Journal of Pharmaceutics 1989; 51: 253–258
   Google Scholar
• Gupta P. K., Morris C., Hung C. T. Evaluation of magnetic albumin microspheres in site specific delivery of adriamycin in rats. Proceedings of the University of Otago Medical School 1986c; 64: 63–64
   Google Scholar
• Gupta P. K., Morris C., Hung C. T. Magnetic albumin microspheres as carriers for drug targeting. New Zealand Medical Journal 1987c; 100: 253
   Google Scholar
• Gupta P. K., Morris C., Hung C. T., Guiney J., Rao N. S. Evaluation of the ultrastructural disposition of magnetic albumin microspheres in the targeted delivery of adriamycin in rats. Proceedings of the University of Otago Medical School 1987d; 65: 53–54
   Google Scholar
• Hagan L. A., Krejcarek G. E., Taylor A., Alazaraki N. A rapid method for the labeling of albumin microspheres with In-113 and In-111. Journal of Nuclear Medicine 1978; 19: 1055–1058
   PubMedGoogle Scholar
• Halpern B. N., Biozzi G., Benacerraf B., Stiffel C., Hillemand B. Cinetique de la phagocytose d'une serum albumine humaine specialement traitee et radiomarquee, et son application a l'etude de la circulation he'patique chez l'homme. Compte Rendue Societé de Biologie 1956; 150: 1307–1311
   PubMedGoogle Scholar
• Hofer R., Ogris E., Pfeiffer G. Splenoportoscintography to demonstrate portosystemic shunts. Journal of Nuclear Medicine 1968; 9: 624–629
   PubMedGoogle Scholar
• Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspension. Journal of Pharmaceutical Sciences 1961; 50: 874–875
   PubMed Web of Science ®Google Scholar
• Higuchi T. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. Journal of Pharmaceutical Sciences 1963; 52: 1145–1149
   PubMed Web of Science ®Google Scholar
• Hnatowich D. J., Schlegel P. Albumin microspheres labeled with Ga-67 by chelation. Journal of Nuclear Medicine 1981; 22: 623–626
   PubMedGoogle Scholar
• Illum L., Davis S. S. The targeting of drugs parenterally by use of microspheres. Journal of Par enter al Science and Technology 1982; 36: 242–248
   PubMedGoogle Scholar
• Ishizaka T., Koishi M. In vitro, drug release from egg albumin microcapsules. Journal of Pharmaceutical Sciences 1983; 72: 1057–1061
   PubMed Web of Science ®Google Scholar
• Ishizaka T., Ariizumi T., Nakamura T., Koishi M. Preparation of serum albumin microcapsules. Journal of Pharmaceutical Sciences 1985; 74: 342–344
   PubMed Web of Science ®Google Scholar
• Ishizaka T., Endo K., Koishi M. Preparation of egg albumin microcapsules and microspheres. Journal of Pharmaceutical Sciences 1981; 70: 358–363
   PubMed Web of Science ®Google Scholar
• Ishizaka T., Motojima M., Kounosu S., Koishi M. In vitro, release of poly(ethylene oxides) from serum albumin microspheres. Chemical and Pharmaceutical Bulletin 1986; 34: 3341–3347
   PubMedGoogle Scholar
• Ithakissios D. S. U.S. Patent. 1978, In vitro, diagnostic test, 4, 115–534
   Google Scholar
• Juliano R. L. Controlled delivery of drugs: an overview and prospectus. Drug Delivery Systems, R. L. Juliano. Oxford University press, USA 1980; 3–10
   Google Scholar
• Jun H. W., Lai J. W. Preparation and in vitro, dissolution tests of egg albumin microcapsules of nitrofurantoin. International Journal of Pharmaceutics 1983; 16: 65–67
   Google Scholar
• Kato T. Encapsulated drugs in targeted cancer therapy. Controlled Drug Delivery, S. D. Bruck. CRC Press, Inc., Boca Raton, Fla. 1982; vol II.: 189–240
   Google Scholar
• Kennedy K. A., Rockwell S. pH as a factor modulating the response of tumor cells to chemotherapy. Proceedings of American Association of Cancer Research 1986; 27: 235
   Google Scholar
• Kondo T., Koishi M. Microcapsules. Sankyo Shuppan. 1977; 98–108
   Google Scholar
• Kramer P. A. Albumin microspheres as vehicles for achieving specificity in drug delivery. Journal of Pharmaceutical Sciences 1974; 63: 1646–1647
   PubMed Web of Science ®Google Scholar
• Kramer P. A., Burnstein T. Phagocytosis of microsphere containing anticancer agent by tumor cells in vitro. Life Science 1976; 19: 515–520
   PubMed Web of Science ®Google Scholar
• Lee T. K., Sokoloski T. D., Royer G. P. Serum albumin beads: an injectable, biodegradable system for the sustained release of drugs. Science 1981; 213: 233–235
   PubMed Web of Science ®Google Scholar
• Leucuta S. E., Risca R., Daicoviviu D., Porutiu D. Albumin microspheres as a drug delivery system for epirubicin: pharmaceutical, pharmacokinetic and biological aspects. International Journal of Pharmaceutics 1988; 41: 213–217
   Web of Science ®Google Scholar
• Longo W. E., Goldberg E. P. Hydrophilic albumin microspheres. Methods in Enzymology 1985; 112: 18–26
   PubMed Web of Science ®Google Scholar
• Longo W. E., Iwato H., Lindheimer T. A., Goldberg E. P. Preparation of hydrophilic albumin microspheres using polymeric dispersing agents. Journal of Pharmaceutical Sciences 1982; 71: 1323–1327
   PubMed Web of Science ®Google Scholar
• McArdle C. S., Lewi H., Willmott N. Adriamycin-loaded albumin microspheres: a new method of delivering cytotoxic chemotherapy. IIIrd World Conference on Clinical Pharmacology and Experimental Therapeutics, Stockholm, 1986
   Google Scholar
• McLeod A. D., Lam F. C., Gupta P. K., Hung C. T. Optimised synthesis of polyglutaraldehyde nanoparticles using central composite design. Journal of Pharmaceutical Sciences 1988; 77: 704–710
   PubMed Web of Science ®Google Scholar
• Martodam R. R., Twumasi D. Y., Liener I. E., Powers J. C., Nishino N., Krejcareck G. Albumin microspheres as carriers of an inhibitor of leukocyte elastase: Potential therapeutic agent for emphysema. Proceedings of the National Academy of Science, USA, 1979; 76: 2128–2132
   Google Scholar
• Marty J. J., Oppenheim R. C. Colloidal systems for drug delivery. Australian Journal of Pharmaceutical Sciences 1977; 6: 65–76
   Google Scholar
• Marty J. J., Oppenheim R. C., Speiser P. Nanoparticles: A new colloidal drug delivery system. Pharmaceutica Acta Helvetica 1978; 53: 17–23
   PubMedGoogle Scholar
• Margalit R., Silbiger E. Albumin microspheres as delivery system for photodynamic drugs: physico-chemical studies and their implications for in vivo, situations. Journal of Microencapsulation 1985; 2: 183–196
   PubMedGoogle Scholar
• Morimoto Y., Fujimoto S. Albumin microspheres as a drug carrier. CRC Critical Review in Therapeutic Drug Carrier Systems. 1985; 2: 19–63
   PubMedGoogle Scholar
• Morimoto Y., Akimoto M., Sugibayashi K., Nadai T., Kato Y. Drug carrier property of albumin microspheres in chemotherapy. IV. Antitumour effect of single shot or multiple shot administration of microsptieres entrapped 5-FU on Ehrlich ascites or solid tumour in mice. Chemical and Pharmaceutical Bulletin 1980a; 28: 3087–3092
   PubMed Web of Science ®Google Scholar
• Morimoto Y., Okumura M., Sugibayashi K., Kato Y. Biomedical applications of magnetic fluids. II. Preparation and magnetic guidance of magnetic albumin microspheres for site specific drug delivery in vivo. Journal of Pharmacobio-Dynamics 1981b; 4: 624–631
   PubMedGoogle Scholar
• Morimoto Y., Sugibayashi K., Okumura M., Kato Y. Biomedical applications of magnetic fluids. I. Magnetic guidance of ferro colloid entrapped albumin microsphere for site specific drug delivery in vivo. Journal of Pharmacobio Dynamics 1980b; 3: 264–267
   PubMedGoogle Scholar
• Morimoto Y., Sugibayashi K., Kato Y. Drug-carrier property of albumin microspheres in chemotherapy. V. Antitumour effect of microsphere entrapped adriamycin on liver metastasis of AH 7974 cells in rat. Chemical and Pharmaceutical Bulletin 1981a; 29: 1433–1438
   PubMed Web of Science ®Google Scholar
• Morimoto Y., Sugibayashi K., Natsume H., Fujimoto S., Miyazaki M., Tazahashi O., Endoh F., Shrestha R. D. Pharmacokinetic studies on albumin microspheres containing antitumor drugs. Proceedings of the 14th International Congress of Chemotherapy, KyotoJapan, 1985
   Google Scholar
• Mover M. P., Armstrong A., Parra J., Escobar D. Enhanced tumor metastases upon drug delivery in cross linked albumin beads. Clinical & Experimental Metastasis 1986; 4: 63–70
   PubMedGoogle Scholar
• Natsume H., Sugibayashi K., Morimoto Y., Fujimoto S. Preparation and application of albumin microspheres containing antitumour agents as a drug carrier for chemoembolization. Journal of Pharmacobio-Dynamics 1985; 8: s–139
   Google Scholar
• Neutze J. M., Wyler F., Rudolph A. M. Changes in distribution of cardiac output after hemorrhage in rabbits. American Journal of Physiology 1968; 215: 857–864
   PubMedGoogle Scholar
• Oppenheim R. G. Nanoparticles. Drug Delivery Systems, R. L. Juliano. Oxford University Press, USA 1980; 177–188
   Google Scholar
• Oppenheim R. C. Solid colloidal drug delivery systems: nanoparticles. International Journal of Pharmaceutics 1981; 8: 217–234
   Web of Science ®Google Scholar
• Oppenheim R. C., Stewart N. F. The manufacture and tumor cell uptake of nanoparticles labelled with fluorescein isothiocyanate. Drug Development and Industrial Pharmacy 1979; 5: 563–571
   Web of Science ®Google Scholar
• Oppenheim R. C., Gipps E. M., Forbes J. F., Whitehead R. H. Development and testing of proteinaceous nanoparticles containing cytotoxics. Microspheres and Drug Therapy, Pharmaceutical, Immunological and Medical Aspects, S. S. Davis, L. Ilium, J. G. McVie, E. Tomlinson. Elsevier, New York 1984; 117–128
   Google Scholar
• Oppenheim R. C., Marty J. J., Speiser P. U.S. Patent. 1978, Injectable compositions, nanoparticles useful therin and process of manufacturing same, 4, 107–288
   Google Scholar
• Ovadia H., Carbone A. M., Paterson P. Y. Albumin magnetic microspheres: a novel carrier for myelin basic protein. Journal of Immunological Methods 1982; 53: 109–122
   PubMed Web of Science ®Google Scholar
• Parker B. M., Andersen D. C., Smith J. R. Observations on arterio-venous communications in lungs of dogs. Proceedings of the Society of Experimental Biology and Medicine 1958; 98: 306–308
   PubMed Web of Science ®Google Scholar
• Pasqualini R., Plassio G., Sosi S. The preparation of albumin microspheres. Journal of Biology and Nuclear Medicine 1969; 13: 80–84
   PubMedGoogle Scholar
• Poste G., Kirsh R. Site specific (targeted) drug delivery in cancer therapy. Biotechnology 1983; 10: 869–878
   Google Scholar
• Poznansky M. J., Juliano R. L. Biological approaches to the controlled delivery of drugs: a critical review. Pharmacological Reviews 1984; 36: 277–336
   PubMed Web of Science ®Google Scholar
• Prinzmetal M., Simkin B., Bergman H. C., Kruger H. E. Studies on the coronary circulation. II. The collateral circulation of the normal human heart by coronary perfusion with radioactive erythrocytes and glass spheres. American Heart Journal 1947; 33: 420–422
   PubMedGoogle Scholar
• Przyborowski M., Lachnik E., Wiza J., Licinska I. Preparation of HSA microspheres in a one step thermal denaturation of protein aerosol carried in gas medium. European Journal of Nuclear Medicine 1982; 7: 71–72
   PubMedGoogle Scholar
• Pujara S. S., Russell C. D. Evaluation of peritoneo-venous shunt. Journal of Nuclear Medicine 1979; 20: 72–73
   PubMedGoogle Scholar
• Raju A., Mani R., Divekar K. D., Narsimhan D. V. S., Rahalkar A. D., Lal R., Sundararajan Kotrappa P., Mani R. S. Human serum albumin microspheres for lung imaging. Preparation and evaluation. Isotopenpraxis 1978; 14: 57–61
   Web of Science ®Google Scholar
• Ratcliffe J. H., Hunneyball I. M., Smith A., Wilson C. G., Davis S. S. Preparation and evaluation of biodegradable polymeric systems for the intra-articular delivery of drugs. Journal of Pharmacy and Pharmacology 1984; 36: 431–436
   PubMed Web of Science ®Google Scholar
• Ratcliffe J. H., Hunneyball I. M., Wilson C. G., Smith A., Davis S. S. Albumin microspheres for intra-articular drug delivery: investigation of their retention in normal and arthritic knee joints of rabbits. Journal of Pharmacy and Pharmacology 1987; 39: 290–295
   PubMed Web of Science ®Google Scholar
• Remington Pharmaceutical Sciences, 15th ed. Mack Publishing Company, Pennsylvania 1975; 1079
   Google Scholar
• Reske S. N., Vyska K., Feinendegen L. E. Kinetics of phagocytosis and proteolytic metabolism in liver macrophages in normal persons and tumour patients. Journal of Nuclear Medicine 1979; 20: 606
   Web of Science ®Google Scholar
• Reske S. N., Vyska K., Feinendegen L. E. In vivo, assessment of phagocytic properties of kupffer cells. Journal of Nuclear Medicine 1981; 22: 405–410
   PubMed Web of Science ®Google Scholar
• Rhodes B. A., Zolle I., Buchanan J. W., Wagner H. N. Radioactive albumin microspheres for studies of the pulmonary circulation. Radiology 1969; 92: 1453–1460
   PubMed Web of Science ®Google Scholar
• Royer G. P. U.S. Patent. 1982, Implants, microbeads, microcapsules, preparation thereof and method of administering a biologically active substance to an animal, 4, 349–530
   Google Scholar
• Reske S. N., Vyska K., Feinendegen L. E. Kinetics of phagocytosis and proteolytic metabolism in liver macrophages in normal persons and tumour patients. Journal of Nuclear Medicine 1979; 20: 606
   Web of Science ®Google Scholar
• Royer G. P., Lee T. K., Sokoloski T. D. Entrapment of bioactive compounds within albumin beads. Journal oj Par enter al Science & Technology 1983; 37: 34–37
   PubMedGoogle Scholar
• Samy T. S. A., Wellham L. L., Yen R. C. K., Kim S., Krishan A. Antitumor activity of doxorubicin entrapped in albumin microspheres. Proceedings of the American Association of Cancer Research 1986; 27: 404
   Google Scholar
• Scheffel U., Rhodes B. A., Natarajan T. K., Wagner M. N. Albumin microspheres for study of the reticuloendothelial system. Journal of Nuclear Medicine 1972; 13: 498–503
   PubMed Web of Science ®Google Scholar
• Senvei A. E., Widder K. J. U.S. Patent. 1980, Method of magnetic separation of cells and the like, and microspheres for use theirin, 4, 230, 685
   Google Scholar
• Senyei A. E., Widder K. J. U.S. Patent. 1982, Method of incorporating water soluble heat sensitive therapeutic agents in albumin microspheres, 4, 357, 359
   Google Scholar
• Senyei A. E., Reich S. D., Gonczy C., Widder K. J. In vivo, kinetics of magnetically targeted low-dose doxorubicin. Journal of Pharmaceutical Sciences 1981; 70: 389–391
   PubMed Web of Science ®Google Scholar
• Senyei A., Widder K., Czerlinski G. Magnetic guidance of drug carrying microspheres. Journal of Applied Physics 1978; 49: 3578–3583
   Web of Science ®Google Scholar
• Sheu M.-T., Moustafa M. A., Sokoloski T. D. Entrapment of bioactive compounds within native albumin beads. II. Effects of rate and extent of cross-linking on microbeads properties. Journal of Parenteral Science and Technology 1986; 40: 253–258
   PubMedGoogle Scholar
• Sheu M. T., Sokoloski T. D. Entrapment of bioactive compounds within native albumin beads. III. Evaluation of parameters affecting drug release. Journal of Parenteral Science and Technology 1986; 40: 259–265
   PubMedGoogle Scholar
• Sokoloski T. D., Royer G. P. Drug entrapment within native albumin beads. Microspheres and Drug Therapy. Pharmaceutical, Immunological and Medical Aspects, S. S. Davis, L. Ilium, J. G. McVie, E. Tomlinson. Elsevier, Amsterdam 1984; 295–308
   Google Scholar
• Spenlehauer G., Veillard M., Benoit J.-P. Formulation and characterization of cisplatin loaded poly(d,l-lactide) microspheres for chemoembolization. Journal of Pharmaceutical Sciences 1986; 75: 750–755
   PubMed Web of Science ®Google Scholar
• Sugibayashi K., Akimoto M., Morimoto Y., Nadai T., Kato Y. Drugcarrier property of albumin microspheres in chemotherapy. III. Effect of microsphereentrapped 5-fluorouracil on ehrlich ascites carcinoma in mice. Journal of Pharmacobio Dynamics 1979b; 2: 350–355
   Google Scholar
• Sugibayahshi K., Morimoto Y., Nadai T., Kato Y. Drug carrier property of albumin microspheres in chemotherapy. 1. Tissue distribution of microcapsule entrapped 5-fluorouracil in mice. Chemical and Pharmaceutical Bulletin 1977; 25: 3433–3434
   PubMedGoogle Scholar
• Sugibahashi K., Morimoto Y., Nadai T., Kato Y., Hasegawaw A., Arita T. Drug carrier property of albumin microspheres in chemotherapy: 2. Preparation and tissue distribution in mice of microsphere entrapped 5-fluorouracil. Chemical and Pharmaceutical Bulletin 1979a; 27: 204–209
   PubMedGoogle Scholar
• Sugibayahshi K., Okumura M., Morimoto Y. Biomedical applications of magnetic fluids. III. Antitumour effect of magnetic albumin microsphere-entrapped adriamycin on lung metastasis of AH 7974 in rats. Biomaterials 1982; 3: 181–186
   PubMedGoogle Scholar
• Takahasi I., Ohnuma T., Kavy S., Bharadwaj S., Holland J. F. Interaction of human serum albumin with anticancer agents in vitro. British Journal of Cancer 1980; 41: 602–608
   PubMedGoogle Scholar
• Taplin G. V., Johnson D. E., Dore E. K., Kaplan H. S. Suspensions of radioalbumin aggregates for photoscanning of the liver, spleen, lung and other organs. Journal of Nuclear Medicine 1964; 5: 259–275
   PubMed Web of Science ®Google Scholar
• Thies C. Microcapsules as drug delivery devices. CRC Critical Reviews in Biomedical Engineering 1982; 8: 335–383
   PubMed Web of Science ®Google Scholar
• Thies C., Bissery M. Biodegradable microspheres for parenteral administration. Biomedical Applications of Microencapsulation, F. Lim. CRC press, Boca Raton, Florida 1984; 53–74
   Google Scholar
• Tomlinson E. Microsphere delivery systems for drug targeting and controlled release. International Journal of Pharmaceutical Technology and Product Manufacturing 1983; 4: 49–57
   Google Scholar
• Tomlinson E. Passive and active vectoring with microparticles: localisation and drug release. Journal of Controlled Release 1985; 2: 385–391
   Google Scholar
• Tomlinson E., Burger J. J. Incorporation of water soluble drugs in albumin microspheres. Methods in Enzymology 1985; 112: 27–43
   PubMed Web of Science ®Google Scholar
• Tomlinson E., Burger J. J., McVie J. G., Hoefnagel K. Albumin microspheres for intra-arterial drug targeting. Recent Advances in Drug Delivery Systems, J. M. Anserson, S. W. Kim. Plenum Press, NY 1984a; 199–208
   Google Scholar
• Tomlinson E., Burger J. J., Schoonderwoerd E. M. A., Kuik J., Schlotz F. C., McVie J. G., Mills S. Preparation and characterization of albumin microspheres for intra-arterial tumour targeting of cytotoxic compounds. Journal of Pharmacy and Pharmacology 1982; 34: 88P
   Google Scholar
• Tomlinson E., Burger J. J., Schoonderwoerd E. M. A., McVie J. G. Human serum albumin microspheres for intraarterial drug targeting of cytostatic compounds. Pharmaceutical aspects and release characteristics. Microspheres and Drug Therapy. Pharmaceutical, Immunological and Medical Aspects, S. S. Davis, L. Ilium, J. G. McVie, E. Tomlinson. Elsevier, New York 1984b; 75–90
   Google Scholar
• Ueda H., Kitani K., Kameda H., Yamada H., Iio M. Detection of hepatic shunts by the use of 131I-macroaggregated albumin. Gasteroenterology 1967; 52: 480–487
   PubMedGoogle Scholar
• Wagner S. J., Welch M. J. Gallium-68 labelling of albumin and albumin microspheres. Journal of Nuclear Medicine 1979; 20: 428–433
   PubMedGoogle Scholar
• Wagner H. N., Jr., Rhodes B. A., Sasaki Y., Ryan J. P. Studies of the circulation with radioactive microspheres. Investigative Radiology 1969; 4: 374–386
   PubMed Web of Science ®Google Scholar
• Wagner H. N., Jr., Sabistan D. C., Jr., McAfee J. G., Tow D. E., Stern H. S. Diagnosis of massive pulmonary embolism in man by radioisotope scanning. The New England Journal of Medicine 1964; 271: 377–384
   PubMed Web of Science ®Google Scholar
• Widder K. J., Senyei A. E. U.S. Patent. 1981, Intravascularly-administrable, magnetically localizable biodegradable carrier, 4, 247–406
   Google Scholar
• Widder K. J., Flouret G., Senyei A. E. Magnetic microspheres: synthesis of a novel parenteral drug carrier. Journal of Pharmaceutical Sciences 1979b; 68: 79–82
   PubMed Web of Science ®Google Scholar
• Widder K. J., Senyei A. E., Ovadia H., Paterson Y. Magnetic protein A microspheres: A rapid method for cell separation. Clinical Immunology and Immunopathology 1979c; 14: 395–400
   PubMedGoogle Scholar
• Widder K. J., Senyei A. E., Ovadia H., Paterson Y. Specific cell binding using staphyloccocal protein A magnetic microspheres. Journal of Pharmaceutical Sciences 1981; 70: 387–389
   PubMed Web of Science ®Google Scholar
• Widder K. J., Senyei A. E., Ranney D. F. Magnetically responsive microspheres and other carriers for the biophysical targeting of antitumor agents. Advances in Pharmacology and Chemotherapy, S. Garattini, A. Goldin, F. Howking, I. J. Kopin, R. J. Schnitzer. Academic Press, NY 1979a; 16: 213
   Google Scholar
• Widder K. J., Senyei A. E., Ranney D. F. In vitro, release of biologically active adriamycin by magnetically responsive albumin microspheres. Cancer Research 1980; 40: 3512–3517
   PubMed Web of Science ®Google Scholar
• Widder K. J., Senyei A. E., Scarpelli D. G. Magnetic microspheres: a model system for site specific delivery. Proceedings of the Society of Experimental Biology and Medicine 1978; 58: 141–146
   Google Scholar
• Willmott N., Cummings J. Increases anti-tumor effect of adriamycin-loaded albumin microspheres is associated with anaerobic bioreduction of drug in tumor tissue. Biochemical Pharmacology 1987; 36: 521–526
   PubMed Web of Science ®Google Scholar
• Willmott N., Harrison P. J. Characterization of freeze-dried albumin microspheres containing anti-cancer drug adriamycin. International Journal of Pharmaceutics 1988; 43: 161–166
   Web of Science ®Google Scholar
• Willmott N., Cummings J., Stuart J. F. B., Florence A. T. Adriamycin-loaded albumin microspheres: lung entrapment and fate in the rat. Biopharmaceutics and Drug Disposition 1985a; 6: 91–104
   PubMed Web of Science ®Google Scholar
• Willmott N., Cummings J., Florance A. T. In vitro, release of adriamycin from drug-loaded albumin and haemoglobin microspheres. Journal of Microencapsulation 1985b; 2: 293–304
   PubMedGoogle Scholar
• Willmott N., Kamel H. M. H., Cummings J., Stuart J. F. B., Florence A. T. Adriamycin-loaded albumin microspheres: Lung entrapment and fate in the rat. Microspheres and Drug Therapy Pharmaceutical, Immunological and Medical Aspects, S. S. Davis, L. Ilium, J. G. McVie, E. Tomlinson. Elsevier, New York 1984; 205–216
   Google Scholar
• Yapel A. F. U.S. Patent. 1979, Albumin medicament carrier system, 4, 147–767
   Google Scholar
• Yapel A. F. Albumin microspheres: heat and chemical stabilization. Methods in Enzymology 1985; 112: 3–17
   Web of Science ®Google Scholar
• Yvert J. P., Maziere B., Verhas M., Comar D. Simple, fast preparation of Gallium-68-labelled human serum albumin microspheres. European Journal of Nuclear Medicine 1979; 4: 95–99
   PubMedGoogle Scholar
• Zolle I. U.S. Patent. 1976, Methods of incorporating substances into protein microspheres, 3, 937-668
   Google Scholar
• Zolle I., Hosain F., Rhodes B. A., Wagner H. N., Jr. Human serum albumin microspheres for studies of the reticuloendothelial system. Journal of Nuclear Medicine 1970; 11: 379
   Web of Science ®Google Scholar
• Zolle I., Rhodes B. A., Wagner H. N., Jr. Preparation of metabolized radioactive human serum albumin microspheres for studies of the circulation. International Journal of Applied Radiation and Isotopes 1970; 21: 155–167
   PubMedGoogle Scholar